Vous êtes sur la page 1sur 2

Federal Register / Vol. 73, No.

54 / Wednesday, March 19, 2008 / Notices 14839

Drug Schedule DEPARTMENT OF JUSTICE of the procedures described in 21 CFR


1301.34(b), (c), (d), (e) and (f). As noted
Oxymorphone (9652) ................... II Drug Enforcement Administration in a previous notice published in the
Alfentanil (9737) ........................... II Federal Register on September 23, 1975,
Fentanyl (9801) ............................ II Importer of Controlled Substances; (40 FR 43745), all applicants for
Sufentanil (9740) .......................... II Notice of Application registration to import a basic class of
Pursuant to 21 U.S.C. 958(i), the any controlled substances in schedule I
The company plans to import Attorney General shall, prior to issuing or II are and will continue to be required
analytical reference standards for a registration under this Section to a to demonstrate to the Deputy Assistant
distribution to its customers for research bulk manufacturer of a controlled Administrator, Office of Diversion
purposes. substance in schedule I or II and prior Control, Drug Enforcement
to issuing a regulation under 21 U.S.C. Administration, that the requirements
Any bulk manufacturer who is for such registration pursuant to 21
presently, or is applying to be, 952(a) authorizing the importation of
such a substance, provide U.S.C. 958(a); 21 U.S.C. 823(a); and 21
registered with DEA to manufacture CFR 1301.34(b), (c), (d), (e) and (f) are
such basic classes of controlled manufacturers holding registrations for
the bulk manufacture of the substance satisfied.
substances listed in schedule I or II,
an opportunity for a hearing. Dated: March 10, 2008.
which fall under the authority of section
Therefore, in accordance with 21 CFR Joseph T. Rannazzisi,
1002(a)(2)(B) of the Act (21 U.S.C. 1301.34(a), this is notice that on
952(a)(2)(B)) may file comments or Deputy Assistant Administrator, Office of
February 14, 2008, Roche Diagnostics Diversion Control, Drug Enforcement
objections to the issuance of the Operations, Inc., Attn: Regulatory Administration.
proposed registration and may, at the Compliance, 9115 Hague Road, [FR Doc. E8–5524 Filed 3–18–08; 8:45 am]
same time, file a written request for a Indianapolis, Indiana 46250, made BILLING CODE 4410–09–P
hearing on such application pursuant to application by renewal to the Drug
21 CFR 1301.43 and in such form as Enforcement Administration (DEA) to
prescribed by 21 CFR 1316.47. be registered as an importer of the basic DEPARTMENT OF JUSTICE
Any such comments or objections classes of controlled substances listed in
being sent via regular mail should be schedule I and II: Drug Enforcement Administration
addressed, in quintuplicate, to the Drug Importer of Controlled Substances;
Drug Schedule
Enforcement Administration, Office of Notice of Application
Diversion Control, Federal Register Lysergic acid diethylamide (7315) I
Representative (ODL), Washington, DC Alphamethadol (9605) .................. I Pursuant to 21 U.S.C. 958(i), the
20537, or any being sent via express Tetrahydrocannabinols (7370) ..... I Attorney General shall, prior to issuing
mail should be sent to Drug Cocaine (9041) ............................. II a registration under this section to a
Enforcement Administration, Office of Ecgonine (9180) ........................... II bulk manufacturer of a controlled
Diversion Control, Federal Register Methadone (9250) ........................ II substance in schedule I or II, and prior
Morphine (9300) ........................... II to issuing a regulation under 21 U.S.C.
Representative (ODL), 8701 Morrissette
952(a)(2) authorizing the importation of
Drive, Springfield, VA 22152; and must The company plans to import the such a substance, provide
be filed no later than April 18, 2008. listed controlled substances for the manufacturers holding registrations for
This procedure is to be conducted manufacture of diagnostic products for the bulk manufacture of the substance
simultaneously with and independent distribution to its customers. an opportunity for a hearing.
of the procedures described in 21 CFR Any bulk manufacturer who is Therefore, in accordance with Title 21
1301.34(b), (c), (d), (e) and (f). As noted presently, or is applying to be, Code of Federal Regulations (CFR),
in a previous notice published in the registered with DEA to manufacture 1301.34(a), this is notice that on
Federal Register on September 23, 1975, such basic classes of controlled February 29, 2008, AllTech Associates
(40 FR 43745), all applicants for substances may file comments or Inc., 2051 Waukegan Road, Deerfield,
registration to import a basic class of objections to the issuance of the Illinois 60015, made application to the
any controlled substances in schedule I proposed registration and may, at the Drug Enforcement Administration
or II are and will continue to be required same time, file a written request for a (DEA) to be registered as an importer of
to demonstrate to the Deputy Assistant hearing on such application pursuant to the basic classes of controlled
21 CFR 1301.43 and in such form as substances listed in schedule II:
Administrator, Office of Diversion
prescribed by 21 CFR 1316.47.
Control, Drug Enforcement
Any such comments or objections Drug Schedule
Administration, that the requirements being sent via regular mail should be
for such registration pursuant to 21 addressed, in quintuplicate, to the Drug Cocaine (9041) ............................. II
U.S.C. 958(a); 21 U.S.C. 823(a); and 21 Enforcement Administration, Office of Codeine (9050) ............................. II
CFR 1301.34(b), (c), (d), (e) and (f) are Hydrocodone (9193) ..................... II
Diversion Control, Federal Register Meperidine (9230) ........................ II
satisfied. Representative (ODL), Washington, DC Methadone (9250) ........................ II
Dated: March 10, 2008. 20537, or any being sent via express Morphine (9300) ........................... II
Joseph T. Rannazzisi, mail should be sent to Drug
Enforcement Administration, Office of The company plans to import these
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Diversion Control, Federal Register controlled substances for the
jlentini on PROD1PC65 with NOTICES

Administration. Representative (ODL), 8701 Morrissette manufacture of reference standards.


Drive, Springfield, VA 22152; and must Any bulk manufacturer who is
[FR Doc. E8–5523 Filed 3–18–08; 8:45 am]
be filed no later than April 18, 2008. presently, or is applying to be,
BILLING CODE 4410–09–P
This procedure is to be conducted registered with DEA to manufacture
simultaneously with and independent such basic classes of controlled

VerDate Aug<31>2005 16:50 Mar 18, 2008 Jkt 214001 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 E:\FR\FM\19MRN1.SGM 19MRN1
14840 Federal Register / Vol. 73, No. 54 / Wednesday, March 19, 2008 / Notices

substances may file comments or of Kenco Group, Inc., 350 Corporate DEPARTMENT OF JUSTICE
objections to the issuance of the Place, Chattanooga, Tennessee 37419,
proposed registration and may, at the made application by renewal to the Drug Enforcement Administration
same time, file a written request for a Drug Enforcement Administration
hearing on such application pursuant to Manufacturer of Controlled
(DEA) to be registered as an importer of
21 CFR 1301.43 and in such form as Substances; Notice of Application
Nabilone (7379), a basic class of
prescribed by 21 CFR 1316.47. controlled substance listed in schedule Pursuant to § 1301.33(a) of Title 21 of
Any such comments or objections II. the Code of Federal Regulations (CFR),
being sent via regular mail should be this is notice that on November 30,
addressed, in quintuplicate, to the Drug The company plans to import the
listed controlled substance for 2007, Mallinckrodt Inc., 3600 North
Enforcement Administration, Office of Second Street, St. Louis, Missouri
Diversion Control, Federal Register distribution to its customers.
63147, made application by renewal to
Representative (ODL), Washington, DC Any bulk manufacturer who is the Drug Enforcement Administration
20537, or any being sent via express presently, or is applying to be, (DEA) to be registered as a bulk
mail should be sent to Drug registered with DEA to manufacture manufacturer of the basic classes of
Enforcement Administration, Office of such basic class of controlled substance controlled substances listed in
Diversion Control, Federal Register may file comments or objections to the schedules I and II:
Representative (ODL), 8701 Morrissette issuance of the proposed registration
Drive, Springfield, VA 22152; and must and may, at the same time, file a written Drug Schedule
be filed no later than April 18, 2008. request for a hearing on such
This procedure is to be conducted Tetrahydrocannabinols (7370) ..... I
application pursuant to 21 CFR 1301.43 Codeine-N-oxide (9053) ............... I
simultaneously with, and independent
and in such form as prescribed by 21 Dihydromorphine (9145) ............... I
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted CFR 1316.47. Difenoxin (9168) ........................... I
Any such comments or objections Morphine-N-oxide (9307) ............. I
in a previous notice published in the Normorphine (9313) ..................... I
Federal Register on September 23, 1975, being sent via regular mail should be Norlevorphanol (9634) .................. I
(40 FR 43745), all applicants for addressed, in quintuplicate, to the Drug Amphetamine (1100) .................... II
registration to import a basic class of Enforcement Administration, Office of Methamphetamine (1105) ............ II
any controlled substances in schedule I Diversion Control, Federal Register Methylphenidate (1724) ................ II
or II are, and will continue to be, Representative (ODL), Washington, DC Nabilone (7379) ............................ II
required to demonstrate to the Deputy 20537, or any being sent via express Codeine (9050) ............................. II
Assistant Administrator, Office of Diprenorphine (9058) ................... II
mail should be sent to Drug Etorphine HCL (9059) .................. II
Diversion Control, Drug Enforcement Enforcement Administration, Office of Dihydrocodeine (9120) ................. II
Administration, that the requirements Diversion Control, Federal Register Oxycodone (9143) ........................ II
for such registration pursuant to 21 Representative (ODL), 8701 Morrissette Hydromorphone (9150) ................ II
U.S.C. 958(a); 21 U.S.C. 823(a); and 21 Drive, Springfield, VA 22152; and must Diphenoxylate (9170) ................... II
CFR 1301.34(b), (c), (d), (e), and (f) are be filed no later than April 18, 2008. Ecgonine (9180) ........................... II
satisfied. Hydrocodone (9193) ..................... II
This procedure is to be conducted Levorphanol (9220) ...................... II
Dated: March 11, 2008.
simultaneously with, and independent Meperidine (9230) ........................ II
Joseph T. Rannazzisi, of, the procedures described in 21 CFR Methadone (9250) ........................ II
Deputy Assistant Administrator, Office of 1301.34(b), (c), (d), (e) and (f). As noted Methadone intermediate (9254) ... II
Diversion Control, Drug Enforcement Metopon (9260) ............................ II
Administration.
in a previous notice published in the Dextropropoxyphene, bulk (9273) II
Federal Register on September 23, 1975, Morphine (9300) ........................... II
[FR Doc. E8–5525 Filed 3–18–08; 8:45 am]
(40 FR 43745–46), all applicants for Thebaine (9333) ........................... II
BILLING CODE 4410–09–P
registration to import a basic class of Opium extracts (9610) .................. II
any controlled substances in schedule I Opium fluid extract (9620) ............ II
or II are and will continue to be required Opium tincture (9630) .................. II
DEPARTMENT OF JUSTICE Opium, powdered (9639) ............. II
to demonstrate to the Deputy Assistant Opium, granulated (9640) ............ II
Drug Enforcement Administration Administrator, Office of Diversion Levo-alphacetylmethadol (9648) .. II
Control, Drug Enforcement Oxymorphone (9652) ................... II
Importer of Controlled Substances; Administration, that the requirements Noroxymorphone (9668) .............. II
Notice of Application for such registration pursuant to 21 Phenazocine (9715) ..................... II
U.S.C. 958(a); 21 U.S.C. 823(a); and 21 Alfentanil (9737) ........................... II
Pursuant to 21 U.S.C. 958(i), the Remifentanil (9739) ...................... II
Attorney General shall, prior to issuing CFR 1301.34(b), (c), (d), (e), and (f) are Sufentanil (9740) .......................... II
a registration under this Section to a satisfied. Fentanyl (9801) ............................ II
bulk manufacturer of a controlled Dated: March 11, 2008.
substance in schedule I or II and prior The firm plans to manufacture the
Joseph T. Rannazzisi,
to issuing a registration under 21 U.S.C. listed controlled substances for internal
952(a)(2) authorizing the importation of Deputy Assistant Administrator, Office of use and for sale to other companies.
such a substance, provide Diversion Control, Drug Enforcement Any other such applicant and any
Administration.
manufacturers holding registrations for person who is presently registered with
the bulk manufacture of the substance [FR Doc. E8–5529 Filed 3–18–08; 8:45 am] DEA to manufacture such substances
jlentini on PROD1PC65 with NOTICES

an opportunity for a hearing. BILLING CODE 4410–09–P may file comments or objections to the
Therefore, in accordance with Title 21 issuance of the proposed registration
Code of Federal Regulations (CFR), pursuant to 21 CFR 1301.33(a).
1301.34(a), this is notice that on Any such written comments or
December 3, 2007, Kenco VPI, Division objections being sent via regular mail

VerDate Aug<31>2005 16:50 Mar 18, 2008 Jkt 214001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\19MRN1.SGM 19MRN1

Vous aimerez peut-être aussi